Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 5Leukemia 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Graft vs Host Disease 1Congenital Abnormalities 1Burkitt Lymphoma 1

Interventions

Methotrexate 10Cyclophosphamide 8Cyclosporine 6Tacrolimus 4Mycophenolic Acid 4Sirolimus 3Antilymphocyte Serum 3fludarabine 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Pentostatin 2Methylprednisolone 2Cyclosporins 2Busulfan 2trihexyltetradecylphosphonium chloride 1thymoglobulin 1ruxolitinib 1merphos 1ibrutinib 1fludarabine phosphate 1aldesleukin 1Whole-Body Irradiation 1Thiotepa 1Therapeutics 1Rituximab 1Proto-Oncogene Proteins c-raf 1Prednisone 1Photopheresis 1Methylprednisolone Hemisuccinate 1Methylprednisolone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Graft vs Host Disease × Clofarabine × Clear all
NCT01471444 2021-12-16

Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

M.D. Anderson Cancer Center

Phase 3 Completed
256 enrolled 13 charts
MyeloidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡